Suven Pharmaceuticals Limited Share Price Bombay S.E.
Equities
SUVENPHAR
INE03QK01018
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
644.4 INR | -2.04% | +1.07% | -11.25% |
27/03 | Suven Pharmaceuticals Limited Announces Shifting of Registered Office | CI |
05/03 | Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call |
Sales 2023 | 13.4B 161M | Sales 2024 * | 10.9B 131M | Capitalization | 168B 2.01B |
---|---|---|---|---|---|
Net income 2023 | 4.11B 49.3M | Net income 2024 * | 3.34B 40.06M | EV / Sales 2023 | 8.97 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 15.4 x |
P/E ratio 2023 |
29.2
x | P/E ratio 2024 * |
50.2
x | Employees | 1,193 |
Yield 2023 * |
0.36% | Yield 2024 * |
0.27% | Free-Float | 37.48% |
Latest transcript on Suven Pharmaceuticals Limited
1 day | -2.04% | ||
1 week | +1.07% | ||
Current month | -4.75% | ||
1 month | -3.87% | ||
3 months | -5.80% | ||
6 months | +14.60% | ||
Current year | -11.25% |
Managers | Title | Age | Since |
---|---|---|---|
Sudhir Singh
CEO | Chief Executive Officer | - | 29/23/29 |
Himanshu Agarwal
DFI | Director of Finance/CFO | 30 | 01/01 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 29/23/29 | |
Shweta Jalan
BRD | Director/Board Member | 48 | 09/11 |
Director/Board Member | 62 | 09/11 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 644.4 | -2.04% | 7 479 |
26/24/26 | 657.9 | +2.02% | 3,939 |
25/24/25 | 644.8 | +1.27% | 5,898 |
24/24/24 | 636.8 | -1.10% | 1,651 |
23/24/23 | 643.8 | +0.98% | 5,883 |
Delayed Quote Bombay S.E., April 29, 2024 at 03:30 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+26.70% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.77% | 231B | |
+5.26% | 200B | |
-8.83% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SUVENPHAR Stock
- SUVENPHAR Stock